{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:51:28Z","timestamp":1758361888553,"version":"3.44.0"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,9,20]]},"DOI":"10.1248\/bpb.b25-00185","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T22:08:00Z","timestamp":1758319680000},"page":"1412-1418","source":"Crossref","is-referenced-by-count":0,"title":["Preadministration of Docetaxel Increases Antioxidant Activity in Myocardial Tissue"],"prefix":"10.1248","volume":"48","author":[{"given":"Mari","family":"Tomonari","sequence":"first","affiliation":[{"name":"Department of Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"},{"name":"Department of Hospital Pharmacy, Nagasaki University Hospital of Medicine and Dentistry, 1\u20137\u20131 Sakamoto, Nagasaki 852\u20138501, Japan"},{"name":"Toyama Community Medicine &amp; Laboratory, 40\u20131 Akai, Imizu, Toyama 939\u20130287, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Clinical Pharmacokinetics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyushu University, 3\u20131\u20131 Maidashi, Higashi-ku, Fukuoka 812\u20138582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"To","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"},{"name":"Department of Hospital Pharmacy, Nagasaki University Hospital of Medicine and Dentistry, 1\u20137\u20131 Sakamoto, Nagasaki 852\u20138501, Japan"},{"name":"Toyama Community Medicine &amp; Laboratory, 40\u20131 Akai, Imizu, Toyama 939\u20130287, Japan"},{"name":"Clinical Pharmacokinetics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyushu University, 3\u20131\u20131 Maidashi, Higashi-ku, Fukuoka 812\u20138582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bontenbal M, Creemers GJ, Braun HJ, de Boer AC, Janssen JT, Leys RB, Ruit JB, Goey SH, van der Velden PC, Kerkhofs LG, Schothorst KL, Schmitz PI, Bokma HJ, Verweij J, Seynaeve C. Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre. <i>J. Clin. Oncol.<\/i>, <b>23<\/b>, 7081\u20137088 (2005).","DOI":"10.1200\/JCO.2005.06.236"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nabholtz JM, Falkson C, Campos D, Szanto J, Martin M, Chan S, Pienkowski T, Zaluski J, Pinter T, Krzakowski M, Vorobiof D, Leonard R, Kennedy I, Azli N, Murawsky M, Riva A, Pouillart P. Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial. <i>J. Clin. Oncol.<\/i>, <b>21<\/b>, 968\u2013975 (2003).","DOI":"10.1200\/JCO.2003.04.040"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kodama A, To H, Kinoshita T, Ieiri I, Higuchi S. Influence of dosing schedules on toxicity and antitumour effects of combined cisplatin and docetaxel treatment in mice. <i>J. Pharm. Pharmacol.<\/i>, <b>61<\/b>, 615\u2013621 (2009).","DOI":"10.1211\/jpp\/61.05.0010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) To H, Shin M, Tabuchi M, Sakaguchi H, Takeuchi A, Matsunaga N, Higuchi S, Ohdo S. Influence of dosing schedule on toxicity and antitumor effects of a combination of adriamycin and docetaxel in mice. <i>Clin. Cancer Res<\/i>, <b>10<\/b>, 762\u2013769 (2004).","DOI":"10.1158\/1078-0432.CCR-1000-03"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tabuchi M, To H, Sakaguchi H, Goto N, Takeuchi A, Higuchi S, Ohdo S. Therapeutic index by combination of adriamycin and docetaxel depends on dosing time in mice. <i>Cancer Res.<\/i>, <b>65<\/b>, 8448\u20138454 (2005).","DOI":"10.1158\/0008-5472.CAN-05-1161"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sakaguchi H, Kodama A, Tomonari M, Ando Y, Tabuchi M, To H, Araki R, Kitahara T, Sasaki H, Ohdo S, Higuchi S. Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity. <i>Breast Cancer Res. Treat.<\/i>, <b>109<\/b>, 443\u2013450 (2008).","DOI":"10.1007\/s10549-007-9667-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) To H, Ohdo S, Shin M, Uchimaru H, Yukawa E, Higuchi S, Fujimura A, Kobayashi E. Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats. <i>J. Pharm. Pharmacol.<\/i>, <b>55<\/b>, 803\u2013810 (2003).","DOI":"10.1211\/002235703765951410"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, Muggia FM. Risk factors for doxorubicin-induced congestive heart failure. <i>Ann. Intern. Med.<\/i>, <b>91<\/b>, 710\u2013717 (1979).","DOI":"10.7326\/0003-4819-91-5-710"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Patan\u00e8 S, Marte F, Di Bella G, Curr\u00f2 A, Coglitore S. QT interval prolongation, torsade de pointes and renal disease. <i>Int. J. Cardiol.<\/i>, <b>130<\/b>, e71\u2013e73 (2008).","DOI":"10.1016\/j.ijcard.2007.11.070"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tomonari M, To H, Nishida M, Mishima T, Sasaki H, Kurose H. Mechanism of the cardioprotective effects of docetaxel pre-administration against adriamycin-induced cardiotoxicity. <i>J. Pharmacol. Sci.<\/i>, <b>115<\/b>, 336\u2013345 (2011).","DOI":"10.1254\/jphs.10279FP"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mordente A, Meucci E, Martorana GE, Giardina B, Minotti G. Human heart cytosolic reductases and anthracycline cardiotoxicity. <i>IUBMB Life<\/i>, <b>52<\/b>, 83\u201388 (2001).","DOI":"10.1080\/15216540252774829"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Olson RD, Mushlin PS, Brenner DE, Fleischer S, Cusack BJ, Chang BK, Boucek RJ Jr. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>85<\/b>, 3585\u20133589 (1988).","DOI":"10.1073\/pnas.85.10.3585"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Li T, Singal PK. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. <i>Circulation<\/i>, <b>102<\/b>, 2105\u20132110 (2000).","DOI":"10.1161\/01.CIR.102.17.2105"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Li T, Danelisen I, Singal PK. Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. <i>Mol. Cell. Biochem.<\/i>, <b>232<\/b>, 19\u201326 (2002).","DOI":"10.1023\/A:1014862912783"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Schimmel KJ, Richel DJ, van den Brink RB, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. <i>Cancer Treat. Rev.<\/i>, <b>30<\/b>, 181\u2013191 (2004).","DOI":"10.1016\/j.ctrv.2003.07.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Xu X, Persson HL, Richardson DR. Molecular pharmacology of the interaction of anthracyclines with iron. <i>Mol. Pharmacol.<\/i>, <b>68<\/b>, 261\u2013271 (2005).","DOI":"10.1124\/mol.105.013383"},{"key":"17","unstructured":"17) Dumoulin MJ, Chahine R, Atanasiu R, Nadeau R, Mateescu MA. Comparative antioxidant and cardioprotective effects of ceruloplasmin, superoxide dismutase and albumin. <i>Arzneimittelforschung<\/i>, <b>46<\/b>, 855\u2013861 (1996)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nakano H, Ogita K, Gutteridge JM, Nakano M. Inhibition by the protein ceruloplasmin of lipid peroxidation stimulated by an Fe<sup>3+<\/sup>-ADP-adriamycin complex. <i>FEBS Lett.<\/i>, <b>166<\/b>, 232\u2013236 (1984).","DOI":"10.1016\/0014-5793(84)80086-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sunderman FW Jr, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. <i>Clin. Chem.<\/i>, <b>16<\/b>, 903\u2013910 (1970).","DOI":"10.1093\/clinchem\/16.11.903"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Schosinsky KH, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. <i>Clin. Chem.<\/i>, <b>20<\/b>, 1556\u20131563 (1974).","DOI":"10.1093\/clinchem\/20.12.1556"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Siveski-Iliskovic N, Hill M, Chow DA, Singal PK. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. <i>Circulation<\/i>, <b>91<\/b>, 10\u201315 (1995).","DOI":"10.1161\/01.CIR.91.1.10"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Li T, Danelisen I, Bello-Klein A, Singal PK. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. <i>Cardiovasc. Res.<\/i>, <b>46<\/b>, 523\u2013530 (2000).","DOI":"10.1016\/S0008-6363(00)00039-0"},{"key":"23","unstructured":"23) Wang YM, Madanat FF, Kimball JC, Gleiser CA, Ali MK, Kaufman MW, van Eys J. Effect of vitamin E against adriamycin-induced toxicity in rabbits. <i>Cancer Res.<\/i>, <b>40<\/b>, 1022\u20131027 (1980)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Moniruzzaman M, Khalil MI, Sulaiman SA, Gan SH. Advances in the analytical methods for determining the antioxidant properties of honey: a review. <i>Afr. J. Tradit. Complement. Altern. Med.<\/i>, <b>9<\/b>, 36\u201342 (2011).","DOI":"10.4314\/ajtcam.v9i1.5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Atiphasaworn P, Monggoot S, Gentekaki E, Brooks S, Pripdeevech P. Antibacterial and antioxidant constituents of extracts of endophytic fungi isolated from ocimum basilicum var. thyrsiflora Leaves. <i>Curr. Microbiol.<\/i>, <b>74<\/b>, 1185\u20131193 (2017).","DOI":"10.1007\/s00284-017-1303-1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Blois MS. Antioxidant determinations by the use of a stable free radical. <i>Nature<\/i>, <b>181<\/b>, 1199\u20131200 (1958).","DOI":"10.1038\/1811199a0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kimura T, Yamagishi K, Suzuki M, Shinmoto H. Relative estimation of the radical scavenging activities of agricultural products. <i>Nippon Shokuhin Kagaku Kogaku Kaishi<\/i>, <b>49<\/b>, 257\u2013266 (2002).","DOI":"10.3136\/nskkk.49.257"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ohyama K, Tomonari M, Ichibangase T, To H, Kishikawa N, Nakashima K, Imai K, Kuroda N. A toxicoproteomic study on cardioprotective effects of pre-administration of docetaxel in a mouse model of adriamycin-induced cardiotoxicity. <i>Biochem. Pharmacol.<\/i>, <b>80<\/b>, 540\u2013547 (2010).","DOI":"10.1016\/j.bcp.2010.04.037"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/9\/48_b25-00185\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:02:02Z","timestamp":1758340922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/9\/48_b25-00185\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00185","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"article-number":"b25-00185"}}